跳至主要内容
临床试验/CTRI/2024/07/070018
CTRI/2024/07/070018尚未招募Phase 3 4

The effectiveness of 0.5 percent isobaric bupivacaine plus Dexmedetomidine Vs 0.75 percent ropivacaine plus dexmedetomidine for postoperative analgesia using ultrasound guided transversus abdominis plane block for abdominal surgeries under general anaesthesia : a randomised control study

Dr Harshitha Konanki1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2024年7月15日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
68
试验地点
1
主要终点
Assessment of postoperative analgesia after Transversus Abdominis Plane block in patients undergoing abdominal surgeries using 0.5 percent bupivacaine and dexmedetomidine compared with 0.75 percent ropivacaine and dexmedetomidine

研究概览

简要总结

Transversus Abdominus Plane block can be used to manage postoperative pain in patients undergoing lower abdominal surgeries under general anesthesia. In this study we are comparing two drugs- 0.5% Bupivacaine and 0.75% Ropivacaine with an adjuvant of dexmedetomidine to analyse the duration of postoperative analgesia provided by the drugs. Perioperative hemodynamic status will also be studied

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients between ages of 18 and 65 years, ASA grade 1 and 2 undergoing lower abdominal surgeries under General Anaesthesia.

排除标准

  • ASA grade 3 and 4 Hypersensitivity to Local anaesthesia patients with infection at the site of injection patients who have coagulopathies patients on systemic anticoagulant medications.

结局指标

主要结局

Assessment of postoperative analgesia after Transversus Abdominis Plane block in patients undergoing abdominal surgeries using 0.5 percent bupivacaine and dexmedetomidine compared with 0.75 percent ropivacaine and dexmedetomidine

时间窗: 2 hours, 4 hours, 9 hours, 18 hours, 24 hours

次要结局

  • Assessment of the effect of Transversus Abdominis Plane block on Perioperative hemodynamic status- Heart rate, Non-invasive Blood Pressure, SpO2(2 hours, 4 hours, 9 hours, 18 hours, 24 hours)

研究者

发起方
Dr Harshitha Konanki
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Harshitha Konanki

KLE DR Prabhakar Kore Hospital and MRC

研究点 (1)

Loading locations...

相似试验